Ivim Health is worth it for a narrow group: people without GLP-1 coverage who want a supervised, membership-based path to semaglutide or tirzepatide and can pay cash predictably. It is a weak choice for anyone whose insurance already covers a branded drug at a low copay. The service bundles…
Last updated: June 2026. 5-Amino-1MQ is a research compound, not an FDA-approved drug. Everything known about its effects comes from animal and cell studies; no human efficacy…